Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Other financing activities (2016 - 2025)

Bruker (BRKR) has disclosed Other financing activities for 11 consecutive years, with -$9.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities rose 44.71% year-over-year to -$9.4 million, compared with a TTM value of -$8.3 million through Dec 2025, up 66.67%, and an annual FY2025 reading of -$8.3 million, up 66.67% over the prior year.
  • Other financing activities was -$9.4 million for Q4 2025 at Bruker, down from $6.5 million in the prior quarter.
  • Across five years, Other financing activities topped out at $10.6 million in Q4 2022 and bottomed at -$17.0 million in Q4 2024.
  • Average Other financing activities over 4 years is -$2.4 million, with a median of -$2.3 million recorded in 2022.
  • The sharpest move saw Other financing activities tumbled 5766.67% in 2024, then surged 822.22% in 2025.
  • Year by year, Other financing activities stood at $10.6 million in 2022, then tumbled by 97.17% to $300000.0 in 2023, then crashed by 5766.67% to -$17.0 million in 2024, then surged by 44.71% to -$9.4 million in 2025.
  • Business Quant data shows Other financing activities for BRKR at -$9.4 million in Q4 2025, $6.5 million in Q3 2025, and -$4.3 million in Q2 2025.